Literature DB >> 7012024

Comparison of the effects of different lipopolysaccharides on the serum bactericidal reactions of two strains of Escherichia coli.

R J Allen, G K Scott.   

Abstract

The serum killing of Escherichia coli ML308 225 and PB94 was inhibited by lipopolysaccharide extracted from either organism, but not by lipopolysaccharide from three pathogenic Enterobacteriaceae.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7012024      PMCID: PMC351386          DOI: 10.1128/iai.31.2.831-832.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  5 in total

1.  The serum bactericidal reaction. 3. Antibody and complement requirements for killing a rough Escherichia coli.

Authors:  J N Goldman; S Ruddy; K F Austen; D S Feingold
Journal:  J Immunol       Date:  1969-06       Impact factor: 5.422

2.  Analysis of outer membrane components of Escherichia coli ML308 225 and of a serum-resistant mutant.

Authors:  G L Tee; G K Scott
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

3.  The effect of purified lipopolysaccharide on the bactericidal reaction of human serum complement.

Authors:  R J Allen; G K Scott
Journal:  J Gen Microbiol       Date:  1980-03

4.  A lipopolysaccharide-binding cell-surface protein from Salmonella minnesota. Isolation, partial characterization and occurrence in different Enterobacteriaceae.

Authors:  R Geyer; C Galanos; O Westphal; J R Golecki
Journal:  Eur J Biochem       Date:  1979-07

5.  Interaction of Salmonella typhimurium with phospholipid vesicles. Incorporation of exogenous lipids into intact cells.

Authors:  N C Jones; M J Osborn
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

  5 in total
  4 in total

1.  Determination of serum bactericidal activity with the aid of luminous bacteria.

Authors:  M Barak; S Ulitzur; D Merzbach
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

2.  Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum.

Authors:  J A Odumeru; G M Wiseman; A R Ronald
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

3.  Vwa+ phenotype of Yersinia enterocolitica.

Authors:  R D Perry; R R Brubaker
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

4.  Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum-sensitive strains.

Authors:  N L Schiller
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.